Amgen AMGN
NASDAQ AMGN
$403.04 -4.23 (-1.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amgen (AMGN) Non Operating Interest Expenses (2009 - 2026)

Updated

Amgen's Non Operating Interest Expenses was $673 million in Q2 2026, down 3.0% from $694 million a year earlier but up 2.4% from the prior quarter.

Analysis

Amgen (AMGN) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Amgen's Non Operating Interest Expenses was $2.67 billion through Jun 30, 2026, down 9.3% year-over-year; for FY2025, it came in at $2.76 billion, down 12.7% from FY2024.

  • Non Operating Interest Expenses shows a five-year compound annual growth rate of 16.9% (FY2020 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $3.16 billion in FY2024 (+9.7%), $2.88 billion in FY2023 (+104.5%), $1.41 billion in FY2022 (+17.5%) and $1.2 billion in FY2021 (-5.2%).
  • Quarterly Non Operating Interest Expenses has moved between $295 million (Q1 2022) and $824 million (Q1 2024) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses has declined for seven straight quarters, with an average decline of 8.7% over the last eight quarters.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q2 2023 (growth of 129.3%); the worst was Q2 2025 (a decline of 14.1%).
  • Per Business Quant data, AMGN's Non Operating Interest Expenses in the three quarters before Q2 2026 was $657 million (Q1 2026), $653 million (Q4 2025) and $685 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 281.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -435.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 247.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 673.00 Mn
Mar 31, 2026 657.00 Mn
Dec 31, 2025 653.00 Mn
Sep 30, 2025 685.00 Mn
Jun 30, 2025 694.00 Mn
Mar 31, 2025 723.00 Mn
Dec 31, 2024 747.00 Mn
Sep 30, 2024 776.00 Mn
Jun 30, 2024 808.00 Mn
Mar 31, 2024 824.00 Mn
Dec 31, 2023 821.00 Mn
Sep 30, 2023 759.00 Mn
Jun 30, 2023 752.00 Mn
Mar 31, 2023 543.00 Mn
Dec 31, 2022 415.00 Mn
Sep 30, 2022 368.00 Mn
Jun 30, 2022 328.00 Mn
Mar 31, 2022 295.00 Mn
Dec 31, 2021 335.00 Mn
Sep 30, 2021 296.00 Mn
API Access

Amgen Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AMGN&period=max&api_key=YOUR_API_KEY